Joanne Gerber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joanne Gerber has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Ommer
Institute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland
1 shared publication - Carsten Wessig
Department of Neurology, University Hospital of Würzburg, University of Würzburg, Würzburg, Germany
1 shared publication - Christian Somandin
Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland
1 shared publication - Daniel Gerber
Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland
1 shared publication - Elisa Tinelli
Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland
1 shared publication - Gianluca Figlia
Division of Signal Transduction in Cancer and Metabolism, German Cancer Research Center (DKFZ), Germany
1 shared publication
Latest Publications
- Open Access
- 16 January 2019
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 8
Schwann cells, but not Oligodendrocytes, Depend Strictly on Dynamin 2 Function
Myelination requires extensive plasma membrane rearrangements, implying that molecules controlling membrane dynamics play prominent roles. The large GTPase dynamin 2 (DNM2) is a well-known regulator of membrane remodeling, membrane fission, and vesicular trafficking. Here, we genetically ablated Dnm2 in Schwann cells (SCs) and in oligodendrocytes of mice. Dnm2 deletion in developing SCs resulted in severely impaired axonal sorting and myelination onset. Induced Dnm2 deletion in adult SCs caused a rapidly-developing peripheral neuropathy with abundant demyelination. In both experimental settings, mutant SCs underwent prominent cell death, at least partially due to cytokinesis failure. Strikingly, when Dnm2 was deleted in adult SCs, non-recombined SCs still expressing DNM2 were able to remyelinate fast and efficiently, accompanied by neuropathy remission. These findings reveal a remarkable self-healing capability of peripheral nerves that are affected by SC loss. In the central nervous system, however, we found no major defects upon Dnm2 deletion in oligodendrocytes.
- 16 January 2019
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 8
Open AccessSchwann cells, but not Oligodendrocytes, Depend Strictly on Dynamin 2 Function
Myelination requires extensive plasma membrane rearrangements, implying that molecules controlling membrane dynamics play prominent roles. The large GTPase dynamin 2 (DNM2) is a well-known regulator of membrane remodeling, membrane fission, and vesicular trafficking. Here, we genetically ablated Dnm2 in Schwann cells (SCs) and in oligodendrocytes of mice. Dnm2 deletion in developing SCs resulted in severely impaired axonal sorting and myelination onset. Induced Dnm2 deletion in adult SCs caused a rapidly-developing peripheral neuropathy with abundant demyelination. In both experimental settings, mutant SCs underwent prominent cell death, at least partially due to cytokinesis failure. Strikingly, when Dnm2 was deleted in adult SCs, non-recombined SCs still expressing DNM2 were able to remyelinate fast and efficiently, accompanied by neuropathy remission. These findings reveal a remarkable self-healing capability of peripheral nerves that are affected by SC loss. In the central nervous system, however, we found no major defects upon Dnm2 deletion in oligodendrocytes.